Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ocular Therapeutix Inc (NASDAQ:OCUL)

6.81
BATS BZX Real-Time Price
As of 1:33pm ET
 +0.05 / +0.74%
Today’s Change
4.04
Today|||52-Week Range
17.34
-27.32%
Year-to-Date
No recent news for Ocular Therapeutix Inc.

Today’s Trading

Previous close6.76
Today’s open6.71
Day’s range6.64 - 6.95
Volume7,590
Average volume (3 months)895,238
Market cap$167.8M
Dividend yield--
Data as of 1:33pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+36.43%
Earnings growth (this year)-11.11%
Earnings growth (next 5 years)+43.00%
Revenue growth (last year)+126.68%
P/E ratioNM
Price/Sales124.46
Price/Book1.87

Competitors

 Today’s
change
Today’s
% change
ACRXAcelRx Pharmaceutica...+0.05+1.37%
RGLSRegulus Therapeutics...+0.01+0.30%
SYNSynthetic Biologics ...-0.05-2.82%
MDWDMediwound Ltd+0.07+0.88%
Data as of 1:32pm ET, 09/30/2016

Financials

Next reporting dateNovember 9, 2016
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$1.8M
Annual profit (last year)-$39.7M
Net profit margin-2,271.31%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Amarpreet S. Sawhney
Chief Operating Officer
James Fortune
Corporate headquarters
Bedford, Massachusetts

Forecasts

Search for Jobs